There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...

During a live event, Martin Voss, MD, reviewed the trials of lenvatinib plus pembrolizumab, cabozantinib plus nivolumab, and ...

Florey researchers, in collaboration with practicing clinicians who routinely care for heart surgery patients, have developed ...

Doctor says this common painkiller habit is ruining kidney health across India. Here are 9 kidney myths to stop believing as they can be dangerous.

Why Don't Patients Take Their Phosphate Binders? Online survey findings showed significant challenges with compliance to ...